Speaker Profiles

J. Mark Lievonen, FCA

J. Mark Lievonen, FCA


Sanofi Pasteur Limited

Mark Lievonen is President of Sanofi Pasteur Limited, the Canadian vaccine division of the sanofi-aventis Group.  Sanofi Pasteur researches, develops and manufactures vaccines for Canadians and for export to global markets.

Mr. Lievonen has been with the company since 1983. He started in the treasury department and was promoted to Corporate Vice President, Finance, in 1988. Since 1990, Mr. Lievonen has held a number of senior management positions, including responsibility for the company’s commercial operations.  

Prior to his appointment as President in March 1999, Mr. Lievonen was Senior Vice President and General Manager of the Oncology Business Unit. He was responsible for the strategy and funding of sanofi pasteur’s Cancer Vaccine Program and the global marketing and sales of its cancer immunotherapeutic products.

Mr. Lievonen holds a BBA in accounting and an MBA in finance and marketing from the Schulich School of Business, York University. He is a Chartered Accountant and received his designation in 1981 while working with PricewaterhouseCoopers.

Mr. Lievonen is currently a member of the Board of Directors of Oncolytics Biotech Inc., the Ontario Institute for Cancer Research and BIOTECanada, where he served as Chair from 2000 to May 2003.  He is co-chair of the Ontario-Quebec Private Sector Advisory Committee (PSAC), established as part of the Ontario-Quebec Trade and Cooperation Agreement. Mr. Lievonen is the co-chair of the Centre for the Advancement of Health Innovations and a member of the Ontario Investment and Trade Advisory Council. He serves on the Board of Governors of York University and the Markham Stouffville Hospital Foundation Board.

He was a member of the Board of the Ontario Genomics Institute, and served as Chair from 2004-2008.  He has also served on a number of industry boards and councils such as BIOCouncil, an advisory group to the Government of Ontario, and the Toronto Mayor’s Economic Competitiveness Advisory Committee.

He was Chair of the Steering Committee for the BIO 2002 International Conference which was held in Toronto in June 2002.  He also served as a member of the United Way of Greater Toronto Cabinet, chairing the Health Care Division.  

Mr. Lievonen was the recipient of a Queen’s Golden Jubilee Medallion in 2002 and was named a Chevalier de l'Ordre National de Mérite by the government of France in 2007.  He was elected a Fellow of the Institute of Chartered Accountants of Ontario in 2009.

Our Sponsors